Primary Sclerosing Cholangitis Current

ies widely, averaging approximately 10 to 15 years post-diagnosis. Surveillance for hepatobiliary malignancies remains a critical aspect of patient management due to increased cancer risk. As research progresses, personalized medicine approaches integrating genetic, immu